OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial
Meghan Whalen, Richard Kajubi, Justin Goodwin, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. 443-452
Open Access | Times Cited: 10
Meghan Whalen, Richard Kajubi, Justin Goodwin, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. 443-452
Open Access | Times Cited: 10
Showing 10 citing articles:
The emergence of artemisinin partial resistance in Africa: how do we respond?
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 36
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 36
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda
Robert Zupko, Tran Dang Nguyen, Jean Claude Semuto Ngabonziza, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2775-2784
Open Access | Times Cited: 24
Robert Zupko, Tran Dang Nguyen, Jean Claude Semuto Ngabonziza, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2775-2784
Open Access | Times Cited: 24
Uncovering HIV and malaria interactions: the latest evidence and knowledge gaps
Antía Figueroa-Romero, Anna Saura‐Lázaro, Sheila Martínez Fernández, et al.
The Lancet HIV (2024) Vol. 11, Iss. 4, pp. e255-e267
Closed Access | Times Cited: 10
Antía Figueroa-Romero, Anna Saura‐Lázaro, Sheila Martínez Fernández, et al.
The Lancet HIV (2024) Vol. 11, Iss. 4, pp. e255-e267
Closed Access | Times Cited: 10
Extended Treatment Duration of Artemether‐Lumefantrine in Ugandan Children with HIV on Efavirenz‐Based Antiretroviral Therapy: A Randomized Controlled Pharmacokinetic and Pharmacodynamic Trial
Meghan Whalen, Richard Kajubi, Justin Goodwin, et al.
The Journal of Clinical Pharmacology (2025)
Closed Access
Meghan Whalen, Richard Kajubi, Justin Goodwin, et al.
The Journal of Clinical Pharmacology (2025)
Closed Access
Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children
Justin Goodwin, Richard Kajubi, Kaicheng Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Justin Goodwin, Richard Kajubi, Kaicheng Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Artemether-lumefantrine, mefloquine and atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria in travellers: A retrospective comparative study of efficacy and treatment failures
Vyacheslav Grebenyuk, František Stejskal, Eva Nohýnková, et al.
Travel Medicine and Infectious Disease (2023) Vol. 52, pp. 102549-102549
Open Access | Times Cited: 3
Vyacheslav Grebenyuk, František Stejskal, Eva Nohýnková, et al.
Travel Medicine and Infectious Disease (2023) Vol. 52, pp. 102549-102549
Open Access | Times Cited: 3
Reversing memory/cognitive impairment with medicinal plants targeting inflammation and its crosstalk with other pathologies
Sheena E.B. Tyler, Luke D.K. Tyler
Brain Disorders (2023) Vol. 11, pp. 100094-100094
Open Access | Times Cited: 2
Sheena E.B. Tyler, Luke D.K. Tyler
Brain Disorders (2023) Vol. 11, pp. 100094-100094
Open Access | Times Cited: 2
Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins
Daniel J. Watson, Lizahn Laing, Jacobus P. Petzer, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access
Daniel J. Watson, Lizahn Laing, Jacobus P. Petzer, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access
Optimizing Lumefantrine Dosing for Young Children in High Malaria Burden Countries using Pharmacokinetic – Pharmacodynamic Simulations
Ségolène Siméon, Emma Hughes, Erika Wallender, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 11
Open Access
Ségolène Siméon, Emma Hughes, Erika Wallender, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 11
Open Access
Optimizing Individualized Antimicrobial Dosing in Pediatric Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nadir Yalçın, Yağmur Dirik, İzgi Bayraktar, et al.
Clinical Drug Investigation (2024)
Closed Access
Nadir Yalçın, Yağmur Dirik, İzgi Bayraktar, et al.
Clinical Drug Investigation (2024)
Closed Access
